Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives

Marianne C. Aznar; Jutta Bergler-Klein; Giuseppe Boriani; David J. Cutter; Coen Hurkmans; Mario Levis; Teresa López-Fernández; Alexander R. Lyon; Maja V. Maraldo

doi:10.1016/j.radonc.2024.110336

Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives

Marianne C. Aznar^*, Jutta Bergler-Klein, Giuseppe Boriani, David J. Cutter, Coen Hurkmans, Mario Levis, Teresa López-Fernández, Alexander R. Lyon, Maja V. Maraldo

^*Corresponding author for this work

Department of Clinical Medicine

Research output: Contribution to journal › Editorial › Research › peer-review

Abstract

Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.

Original language	English
Article number	110336
Journal	Radiotherapy and Oncology
Volume	197
Number of pages	4
ISSN	0167-8140
DOIs	https://doi.org/10.1016/j.radonc.2024.110336
Publication status	Published - 2024

Access to Document

10.1016/j.radonc.2024.110336

Cite this

Cardiovascular toxicities of radiotherapy : From practical issues to new perspectives. / Aznar, Marianne C.; Bergler-Klein, Jutta; Boriani, Giuseppe; Cutter, David J.; Hurkmans, Coen; Levis, Mario; López-Fernández, Teresa; Lyon, Alexander R.; Maraldo, Maja V.

In: Radiotherapy and Oncology, Vol. 197, 110336, 2024.

Research output: Contribution to journal › Editorial › Research › peer-review

@article{30ecc16fa3294efcb1d7fcc8998c9904,

title = "Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives",

abstract = "Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.",

author = "Aznar, {Marianne C.} and Jutta Bergler-Klein and Giuseppe Boriani and Cutter, {David J.} and Coen Hurkmans and Mario Levis and Teresa L{\'o}pez-Fern{\'a}ndez and Lyon, {Alexander R.} and Maraldo, {Maja V.}",

year = "2024",

doi = "10.1016/j.radonc.2024.110336",

language = "English",

volume = "197",

journal = "Radiotherapy & Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Cardiovascular toxicities of radiotherapy

T2 - From practical issues to new perspectives

AU - Aznar, Marianne C.

AU - Bergler-Klein, Jutta

AU - Boriani, Giuseppe

AU - Cutter, David J.

AU - Hurkmans, Coen

AU - Levis, Mario

AU - López-Fernández, Teresa

AU - Lyon, Alexander R.

AU - Maraldo, Maja V.

PY - 2024

Y1 - 2024

N2 - Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.

AB - Improvements in cancer survival have led to a growing interest in the prevention of cancer therapy-related adverse events. Among these, cancer therapy-related cardiovascular toxicity (CTR-CVT) is an important cause of morbidity and premature mortality during and after cancer treatment. To assist healthcare professionals in the prevention, monitoring and management of CTR-CVT, the European Society of Cardiology (ESC), in collaboration with the European SocieTy for Radiotherapy and Oncology (ESTRO), the European Hematology Association (EHA) and the International Cardio-Oncology Society (IC-OS), have published the 2022 ESC Guidelines for cardio-oncology. In this article, we summarise the recommendations that can help radiation oncologists in the prevention and monitoring of radiation-induced heart disease (RIHD), and highlight areas where more research and evidence are needed.

U2 - 10.1016/j.radonc.2024.110336

DO - 10.1016/j.radonc.2024.110336

M3 - Editorial

C2 - 38797493

AN - SCOPUS:85195096033

VL - 197

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

M1 - 110336

ER -